{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:21:08Z","timestamp":1787610068438,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"35","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.1038\/s41388-026-03899-2","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:50:57Z","timestamp":1784843457000},"page":"3647-3659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KLF12-mediated suppression of androgen receptor accelerates metastasis in endometrioid endometrial carcinoma by activating epithelial\u2013mesenchymal transition"],"prefix":"10.1038","volume":"45","author":[{"given":"Jian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6994-2747","authenticated-orcid":false,"given":"Huaijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"3899_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"3899_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tem.2022.06.001","volume":"33","author":"M Gjorgoska","year":"2022","unstructured":"Gjorgoska M, Rizner TL. Integration of androgen hormones in endometrial cancer biology. Trends Endocrinol Metab. 2022;33:639\u201351.","journal-title":"Trends Endocrinol Metab"},{"key":"3899_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ygyno.2018.12.018","volume":"153","author":"KJ Jerzak","year":"2019","unstructured":"Jerzak KJ, Duska L, MacKay HJ. Endocrine therapy in endometrial cancer: an old dog with new tricks. Gynecol Oncol. 2019;153:175\u201383.","journal-title":"Gynecol Oncol"},{"key":"3899_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-68","volume":"14","author":"K Lindemann","year":"2014","unstructured":"Lindemann K, Malander S, Christensen RD, Mirza MR, Kristensen GB, Aavall-Lundqvist E, et al. Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO). BMC Cancer. 2014;14:68.","journal-title":"BMC Cancer"},{"key":"3899_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.23.00470","volume":"42","author":"JMA Pijnenborg","year":"2024","unstructured":"Pijnenborg JMA, van Weelden WJ, Reijnen C, Xanthoulea S, Romano A. Redefining the Position of hormonal therapy in endometrial cancer in the era of molecular classification. J Clin Oncol. 2024;42:8\u201312.","journal-title":"J Clin Oncol"},{"key":"3899_CR6","doi-asserted-by":"crossref","unstructured":"Hashimoto C, Miki Y, Tanaka S, Takagi K, Fue M, Doe Z, et al. 17\u03b2-hydroxysteroid dehydrogenase type 2 expression is induced by androgen signaling in endometrial cancer. Int J Mol Sci. 2018;19:1139.","DOI":"10.3390\/ijms19041139"},{"key":"3899_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.905809","volume":"12","author":"X Wu","year":"2022","unstructured":"Wu X, Zhong X, Huo X, Zhang J, Yang X, Zhang Y. The clinicopathological significance and prognostic value of androgen receptor in endometrial carcinoma: a meta-analysis. Front Oncol. 2022;12:905809.","journal-title":"Front Oncol"},{"key":"3899_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04996-2","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang J, Shou Y, Xu W, Huang Z, Xu J, et al. Restoring the epigenetically silenced lncRNA COL18A1-AS1 represses ccRCC progression by lipid browning via miR-1286\/KLF12 axis. Cell Death Dis. 2022;13:578.","journal-title":"Cell Death Dis"},{"key":"3899_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13045-022-01272-w","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu Y, Shi M, He X, Cao Y, Liu P, Li F, et al. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma. J Hematol Oncol. 2022;15:52.","journal-title":"J Hematol Oncol"},{"key":"3899_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13578-021-00556-x","volume":"11","author":"D Zhou","year":"2021","unstructured":"Zhou D, Gu J, Wang Y, Wu H, Cheng W, Wang Q, et al. Long non-coding RNA NEAT1 transported by extracellular vesicles contributes to breast cancer development by sponging microRNA-141-3p and regulating KLF12. Cell Biosci. 2021;11:68.","journal-title":"Cell Biosci"},{"key":"3899_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10863-021-09879-3","volume":"53","author":"C Xu","year":"2021","unstructured":"Xu C, Shao Y, Liu J, Yao X, Quan F, Zhao Q, et al. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p\/KLF12 axis. J Bioenerg Biomembr. 2021;53:235\u201345.","journal-title":"J Bioenerg Biomembr"},{"key":"3899_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ygyno.2018.10.028","volume":"152","author":"L Ding","year":"2019","unstructured":"Ding L, Ding Y, Kong X, Wu J, Fu J, Yan G, et al. Dysregulation of Kruppel-like factor 12 in the development of endometrial cancer. Gynecol Oncol. 2019;152:177\u201384.","journal-title":"Gynecol Oncol"},{"key":"3899_CR13","doi-asserted-by":"crossref","unstructured":"Ma\u010dek P, Molinari N, Sobo\u010dan M, Knez J. What role do androgens play in endometrial cancer? J Pers Med. 2023;13:341.","DOI":"10.3390\/jpm13020341"},{"key":"3899_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40618-022-01916-1","volume":"46","author":"X Wu","year":"2023","unstructured":"Wu X, Zhang K, Zhong X, Huo X, Zhang J, Tian W, et al. Androgens in endometrial carcinoma: the killer or helper? J Endocrinol Invest. 2023;46:457\u201364.","journal-title":"J Endocrinol Invest"},{"key":"3899_CR15","first-page":"160","volume":"32","author":"M Nisar","year":"2020","unstructured":"Nisar M, Mushtaq S, Hassan U, Akhtar N, Azma M. Androgen receptor expression in endometrial carcinoma and its correlation with estrogen receptor and progesterone receptor and clinicopathological findings. J Ayub Med Coll Abbottabad. 2020;32:160\u20134.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"3899_CR16","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.5001\/omj.2021.53","volume":"36","author":"N Abu Shahin","year":"2021","unstructured":"Abu Shahin N, Aladily T, Abu Alhaj N, Al-Khader A, Alqaqa S, Aljaberi R, et al. Differential expression of androgen receptor in type I and type II endometrial carcinomas: a clinicopathological analysis and correlation with outcome. Oman Med J. 2021;36:e245.","journal-title":"Oman Med J"},{"key":"3899_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/PGP.0000000000000355","volume":"36","author":"Z Mahdi","year":"2017","unstructured":"Mahdi Z, Abdulfatah E, Pardeshi V, Hassan O, Schultz D, Morris R, et al. The impact of androgen receptor expression on endometrial carcinoma recurrence and survival. Int J Gynecol Pathol. 2017;36:405\u201311.","journal-title":"Int J Gynecol Pathol"},{"key":"3899_CR18","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/bjc.2016.16","volume":"114","author":"AM Kamal","year":"2016","unstructured":"Kamal AM, Bulmer JN, DeCruze SB, Stringfellow HF, Martin-Hirsch P, Hapangama DK. Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival. Br J Cancer. 2016;114:688\u201396.","journal-title":"Br J Cancer"},{"key":"3899_CR19","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41388-020-01598-0","volume":"40","author":"N Formaggio","year":"2021","unstructured":"Formaggio N, Rubin MA, Theurillat JP. Loss and revival of androgen receptor signaling in advanced prostate cancer. Oncogene. 2021;40:1205\u201316.","journal-title":"Oncogene"},{"key":"3899_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.04.010","volume":"516","author":"Z Hou","year":"2021","unstructured":"Hou Z, Huang S, Li Z. Androgens in prostate cancer: a tale that never ends. Cancer Lett. 2021;516:1\u201312.","journal-title":"Cancer Lett"},{"key":"3899_CR21","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1158\/0008-5472.CAN-19-1684","volume":"80","author":"R Patel","year":"2020","unstructured":"Patel R, Brzezinska EA, Repiscak P, Ahmad I, Mui E, Gao M, et al. Activation of beta-catenin cooperates with loss of pten to drive AR-independent castration-resistant prostate cancer. Cancer Res. 2020;80:576\u201390.","journal-title":"Cancer Res"},{"key":"3899_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ucl.2021.04.004","volume":"48","author":"MJ Schiewer","year":"2021","unstructured":"Schiewer MJ, Knudsen KE. Basic science and molecular genetics of prostate cancer aggressiveness. Urol Clin North Am. 2021;48:339\u201347.","journal-title":"Urol Clin North Am"},{"key":"3899_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.04.006","volume":"215","author":"G Xiang","year":"2019","unstructured":"Xiang G, Liu F, Liu J, Meng Q, Li N, Niu Y. Prognostic role of Amphiregulin and the correlation with androgen receptor in invasive breast cancer. Pathol Res Pr. 2019;215:152414.","journal-title":"Pathol Res Pr"},{"key":"3899_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10549-019-05216-w","volume":"176","author":"S Kurozumi","year":"2019","unstructured":"Kurozumi S, Joseph C, Raafat S, Sonbul S, Kariri Y, Alsaeed S, et al. Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer. Breast Cancer Res Treat. 2019;176:63\u201373.","journal-title":"Breast Cancer Res Treat"},{"key":"3899_CR25","doi-asserted-by":"crossref","unstructured":"Nita I, Nitipir C, Toma SA, Limbau AM, Pirvu E, Badarau IA, et al. Correlation between androgen receptor expression and immunohistochemistry type as prognostic factors in a cohort of breast cancer patients: result from a single-center, cross sectional study. Healthcare. 2021;9:277.","DOI":"10.3390\/healthcare9030277"},{"key":"3899_CR26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.juro.2018.04.083","volume":"200","author":"ED Crawford","year":"2018","unstructured":"Crawford ED, Schellhammer PF, McLeod DG, Moul JW, Higano CS, Shore N, et al. Androgen receptor targeted treatments of prostate cancer: 35 years of progress with antiandrogens. J Urol. 2018;200:956\u201366.","journal-title":"J Urol"},{"key":"3899_CR27","doi-asserted-by":"crossref","unstructured":"Prabhu JS, Korlimarla A, Rajarajan S, Alexander A, Anupama C, Ramesh R, et al. Abstract PS6-55: the prognostic utility of AR\/ER ratio in young women with breast cancer. Cancer Res. 2021;81:PS6\u201355.","DOI":"10.1158\/1538-7445.SABCS20-PS6-55"},{"key":"3899_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.102958","volume":"138","author":"N Sridhar","year":"2025","unstructured":"Sridhar N, Iwase T, Xie X, Lee J, Damodaran S, Ueno NT. Paving the path ForwARd: advances and challenges in androgen receptor targeting in breast cancer. Cancer Treat Rev. 2025;138:102958.","journal-title":"Cancer Treat Rev"},{"key":"3899_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41591-020-01168-7","volume":"27","author":"TE Hickey","year":"2021","unstructured":"Hickey TE, Selth LA, Chia KM, Laven-Law G, Milioli HH, Roden D, et al. The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer. Nat Med. 2021;27:310\u201320.","journal-title":"Nat Med"},{"key":"3899_CR30","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.neo.2020.07.003","volume":"22","author":"CS Koivisto","year":"2020","unstructured":"Koivisto CS, Parrish M, Bonala SB, Ngoi S, Torres A, Gallagher J, et al. Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma. Neoplasia. 2020;22:484\u201396.","journal-title":"Neoplasia"},{"key":"3899_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0582-2","volume":"16","author":"CS Mak","year":"2017","unstructured":"Mak CS, Yung MM, Hui LM, Leung LL, Liang R, Chen K, et al. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12\/Sp1\/survivin axis. Mol Cancer. 2017;16:11.","journal-title":"Mol Cancer"},{"key":"3899_CR32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.arcmed.2017.06.011","volume":"48","author":"D Marrero-Rodriguez","year":"2017","unstructured":"Marrero-Rodriguez D, la Cruz HA, Taniguchi-Ponciano K, Gomez-Virgilio L, Huerta-Padilla V, Ponce-Navarrete G, et al. Kruppel like factors family expression in cervical cancer cells. Arch Med Res. 2017;48:314\u201322.","journal-title":"Arch Med Res"},{"key":"3899_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102041","volume":"47","author":"H Shi","year":"2024","unstructured":"Shi H, Li J, Yan T, Zhou L, Zhu Y, Guo F, et al. Kr\u00fcppel-like factor 12 decreases progestin sensitivity in endometrial cancer by inhibiting the progesterone receptor signaling pathway. Transl Oncol. 2024;47:102041.","journal-title":"Transl Oncol"},{"key":"3899_CR34","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1210\/me.2007-0242","volume":"21","author":"MC Velarde","year":"2007","unstructured":"Velarde MC, Zeng Z, McQuown JR, Simmen FA, Simmen RC. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells. Mol Endocrinol. 2007;21:2988\u20133001.","journal-title":"Mol Endocrinol"},{"key":"3899_CR35","doi-asserted-by":"publisher","first-page":"21474","DOI":"10.1074\/jbc.M212098200","volume":"278","author":"XL Zhang","year":"2003","unstructured":"Zhang XL, Zhang D, Michel FJ, Blum JL, Simmen FA, Simmen RC. Selective interactions of Kruppel-like factor 9\/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells. J Biol Chem. 2003;278:21474\u201382.","journal-title":"J Biol Chem"},{"key":"3899_CR36","volume":"28","author":"P Shen","year":"2021","unstructured":"Shen P, Cao X, Sun L, Qian Y, Wu B, Wang X, et al. KLF9 suppresses cell growth and induces apoptosis via the AR pathway in androgen-dependent prostate cancer cells. Biochem Biophys Rep. 2021;28:101151.","journal-title":"Biochem Biophys Rep"},{"key":"3899_CR37","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41388-020-01585-5","volume":"40","author":"CM Roggero","year":"2021","unstructured":"Roggero CM, Jin L, Cao S, Sonavane R, Kopplin NG, Ta HQ, et al. A detailed characterization of stepwise activation of the androgen receptor variant 7 in prostate cancer cells. Oncogene. 2021;40:1106\u201317.","journal-title":"Oncogene"},{"key":"3899_CR38","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.2147\/CMAR.S290629","volume":"13","author":"Y Fan","year":"2021","unstructured":"Fan Y, Liu M, Liu A, Cui N, Chen Z, Yang Q, et al. Depletion of circular RNA circ_CORO1C suppresses gastric cancer development by modulating miR-138-5p\/KLF12 Axis. Cancer Manag Res. 2021;13:3789\u2013801.","journal-title":"Cancer Manag Res"},{"key":"3899_CR39","doi-asserted-by":"crossref","unstructured":"Indo S, Orellana-Serradell O, Torres MJ, Castell\u00f3n EA, Contreras HR. Overexpression of REST represses the epithelial-mesenchymal transition process and decreases the aggressiveness of prostate cancer cells. Int J Mol Sci. 2024;25:3332.","DOI":"10.3390\/ijms25063332"},{"key":"3899_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3899_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21:341\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3899_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-020-6687-9","volume":"21","author":"J Jin","year":"2020","unstructured":"Jin J, He X, Silva E. Stable intronic sequence RNAs (sisRNAs) are selected regions in introns with distinct properties. BMC Genomics. 2020;21:287.","journal-title":"BMC Genomics"},{"key":"3899_CR43","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1158\/0008-5472.CAN-20-1791","volume":"80","author":"C Wang","year":"2020","unstructured":"Wang C, Li J. A deep learning framework identifies pathogenic noncoding somatic mutations from personal prostate cancer genomes. Cancer Res. 2020;80:4644\u201354.","journal-title":"Cancer Res"},{"key":"3899_CR44","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1158\/1541-7786.MCR-21-0058","volume":"20","author":"AL Slusher","year":"2022","unstructured":"Slusher AL, Kim JJ, Ribick M, Pollens-Voigt J, Bankhead A, Palmbos PL, et al. Intronic Cis-element DR8 in hTERT Is bound by splicing factor SF3B4 and regulates hTERT splicing in non-small cell lung cancer. Mol Cancer Res. 2022;20:1574\u201388.","journal-title":"Mol Cancer Res"},{"key":"3899_CR45","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/s41388-024-03033-0","volume":"43","author":"Z Yang","year":"2024","unstructured":"Yang Z, Peng Y, Wang Y, Yang P, Huang Z, Quan T, et al. KLF5 regulates actin remodeling to enhance the metastasis of nasopharyngeal carcinoma. Oncogene. 2024;43:1779\u201395.","journal-title":"Oncogene"},{"key":"3899_CR46","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41556-019-0390-6","volume":"21","author":"DC Di Giammartino","year":"2019","unstructured":"Di Giammartino DC, Kloetgen A, Polyzos A, Liu Y, Kim D, Murphy D, et al. KLF4 is involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks. Nat Cell Biol. 2019;21:1179\u201390.","journal-title":"Nat Cell Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03899-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03899-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03899-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:03:08Z","timestamp":1787608988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03899-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":46,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026,9,15]]}},"alternative-id":["3899"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03899-2","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}